We are live on ! Find out more
CRMD.WS

CORMEDIX INC WTS EXP 04/30/15

Delisted

CRMD.WS was delisted on the 29th of April, 2015.

3 hedge funds and large institutions have $11K invested in CORMEDIX INC WTS EXP 04/30/15 in 2013 Q3 according to their latest regulatory filings, with 0 funds opening new positions, 1 increasing their positions, 1 reducing their positions, and closing their positions.

New
Increased
Maintained
Reduced
Closed

0% more funds holding

Funds holding: 33 (0)

0% more repeat investments, than reductions

Existing positions increased: 1 | Existing positions reduced: 1

68% less capital invested

Capital invested by funds: $34K → $11K (-$23K)

Holders
3
Holders Change
Holders Change %
0%
% of All Funds
0.1%
Holding in Top 10
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
Increased
1
Reduced
1
Closed
Calls
Puts
Net Calls
Net Calls Change

Top Buyers

Rank Fund Capital Flow
1
U
UBS
Switzerland
+$104

Top Sellers

Rank Fund Capital Flow
1
AQR Capital Management
AQR Capital Management
Connecticut
-$4.96K
Name Holding Trade Value Shares
Change
Change in
Stake
AQR Capital Management
1
AQR Capital Management
Connecticut
$11K -$4.96K -47,850 -33%
U
2
UBS
Switzerland
+$104 +1,000 +31%

CRMD.WS Hedge Fund Activity: Q3 2013 in Review

3 of the 3,085 institutional investors tracked by Wall St. Rank reported a position in CORMEDIX INC WTS EXP 04/30/15 (CRMD.WS) for Q3 2013, worth a combined $11K — down 68% from $34K a quarter earlier.

Fund positioning in CRMD.WS was balanced in Q3 2013: 0 funds opened new positions, 0 closed out, 1 added to existing stakes and 1 trimmed.

The largest buyer was UBS, adding an estimated $104. The largest seller was AQR Capital Management, cutting an estimated $4.96K.

  • 3 institutional investors held CORMEDIX INC WTS EXP 04/30/15 (CRMD.WS) as of Q3 2013, unchanged from Q2 2013.
  • Funds reported $11K of CORMEDIX INC WTS EXP 04/30/15 stock for Q3 2013, down 68% quarter-over-quarter.
  • 0 funds opened new CORMEDIX INC WTS EXP 04/30/15 positions in Q3 2013 and 0 closed out.
  • The largest CORMEDIX INC WTS EXP 04/30/15 buyer in Q3 2013 was UBS, an estimated $104 added.
  • The largest CORMEDIX INC WTS EXP 04/30/15 seller in Q3 2013 was AQR Capital Management, an estimated $4.96K sold.

Based on aggregated 13F filings for Q3 2013.